Published in Heart Vessels on March 15, 2014
Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. Heart Vessels (2015) 0.78
The saponin DT-13 attenuates tumor necrosis factor-α-induced vascular inflammation associated with Src/NF-кB/MAPK pathway modulation. Int J Biol Sci (2015) 0.76
Aortic smooth muscle cell alterations in mice systemically exposed to arsenic. Heart Vessels (2015) 0.75
AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr (1993) 16.37
Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis (1987) 5.00
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest (2001) 4.98
Nitric oxide synthases: regulation and function. Eur Heart J (2011) 4.71
Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 3.83
Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci U S A (1987) 2.67
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res (1999) 2.60
Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation (2000) 2.39
Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res (2000) 2.28
Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc Res (2006) 1.88
Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (1999) 1.84
A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res (2005) 1.76
Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis (1990) 1.74
Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol (1995) 1.63
Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest (1993) 1.57
Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol (1996) 1.50
Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J (2004) 1.47
The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol (2010) 1.44
VCAM-1 is critical in atherosclerosis. J Clin Invest (2001) 1.30
Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem Genet (1987) 1.28
Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J Lipid Res (1991) 1.05
Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis (2006) 0.96
Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases. Heart Vessels (2011) 0.94
Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol (2000) 0.91
C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile. Atherosclerosis (2000) 0.89
Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. J Lipid Res (2004) 0.87
The role of endoglin in atherosclerosis. Atherosclerosis (2012) 0.84
Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Heart Vessels (2012) 0.80
D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol (2007) 0.80
Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats. Biol Pharm Bull (2009) 0.79
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. Pharmacol Res (2011) 0.78
Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice. J Atheroscler Thromb (2011) 0.77
Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines. Mol Cell Endocrinol (2008) 1.06
Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther (2006) 0.92
Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin Exp Pharmacol Physiol (2006) 0.90
Selected metabolic parameters and the risk for uterine fibroids. Int J Gynaecol Obstet (2008) 0.88
Atorvastatin slows down the deterioration of inner ear function with age in mice. Neurosci Lett (2006) 0.87
Vimentin expression during altered spermatogenesis in rats. Acta Histochem (2005) 0.86
Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures. Toxicol Sci (2011) 0.84
The role of endoglin in atherosclerosis. Atherosclerosis (2012) 0.84
The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity. Chem Res Toxicol (2009) 0.80
The effects of lactoferrin in a rat model of catecholamine cardiotoxicity. Biometals (2008) 0.80
The relationship between serum bilirubin and Crohn's disease. Inflamm Bowel Dis (2014) 0.79
Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice. Circ J (2011) 0.79
Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat. Toxicol Sci (2012) 0.79
Endoglin expression in hyper-cholesterolemia and after atorvastatin treatment in apoE-deficient mice. J Pharm Pharm Sci (2006) 0.78
Cardiac biomarkers in a model of acute catecholamine cardiotoxicity. Hum Exp Toxicol (2009) 0.78
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. Pharmacol Res (2011) 0.78
Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis. Food Funct (2013) 0.77
Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice. J Atheroscler Thromb (2011) 0.77
Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats. Life Sci (2011) 0.77
High Levels of Soluble Endoglin Induce a Proinflammatory and Oxidative-Stress Phenotype Associated with Preserved NO-Dependent Vasodilatation in Aortas from Mice Fed a High-Fat Diet. J Vasc Res (2016) 0.77
Direct administration of rutin does not protect against catecholamine cardiotoxicity. Toxicology (2008) 0.76
Letter by Vitek et al regarding article, "niacin inhibits vascular inflammation via the induction of heme oxygenase-1". Circulation (2012) 0.75
Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys. Nucl Med Biol (2004) 0.75
Microdispersed Oxidized Cellulose as a novel potential substance with hypolipidemic properties. Nutrition (2008) 0.75